Skip to main content

Advertisement

Log in

Semaforin Sema4D in the Immune System in Multiple Sclerosis

  • Immunology and Microbiology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

The expression of class IV semaforin Sema4D and its CD72 receptor on lymphocytes was studied in patients with multiple sclerosis. The disease was associated with an increase in Sema4D level on intact T lymphocytes and with its more intense shedding from the membrane of activated cell. Multiple sclerosis was also associated with a decrease of CD72 receptor expression by B lymphocytes. Possible contribution of Sema4D to the disease development via the direct effects in the CNS and the immunomodulatory effect, specifi cally, B cell activity regulation, was discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. T. Adachi, H. Flaswinkel, H. Yakura, et al., J. Immun., 160, No. 10, 4662-4665 (1998).

    CAS  PubMed  Google Scholar 

  2. G. Disanto, J. M. Morahan, M. H. Barnett, et al., Neurology, 78, No. 11, 823-832 (2012).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. P. Giraudon, P. Vincent, C. Vuaillat, et al., J. Immunol., 172, No. 2, 1246-1255 (2004).

    Article  CAS  PubMed  Google Scholar 

  4. S. L. Hauser, E. Waubant, D. L. Amold, et al., N. Engl. J. Med., 358, No. 7, 676-688 (2008).

    Article  CAS  PubMed  Google Scholar 

  5. H. Kikutani and A. Kumanogoh, Nat. Rev. Immunol., 3, No. 2, 159-167 (2003).

    Article  CAS  PubMed  Google Scholar 

  6. A. L. Kolodkin, D. J. Matthes, and C. S. Goodman, Cell., 75, No. 7, 1389-1399 (1993).

    Article  CAS  PubMed  Google Scholar 

  7. A. Kumanogoh, T. Shikina, C. Watanabe, et al., Int. Immunol., 17, No. 10, 1277-1282 (2005).

    Article  CAS  PubMed  Google Scholar 

  8. A. Kumanogoh, K. Suzuki, E. Ch’ng, et al., J. Immunol., 169, No. 3, 1175-1181 (2002).

    Article  CAS  PubMed  Google Scholar 

  9. A. Kumanogoh, C. Watanabe, I. Lee, et al., Immunity, 13, No. 5, 621-631 (2000).

    Article  CAS  PubMed  Google Scholar 

  10. B. P. Liu and S. M. Strittmatter, Curr. Opin. Cell Biol., 13, No. 5, 619-626 (2001).

    Article  CAS  PubMed  Google Scholar 

  11. M. Mizui, A. Kumanogoh, and H. Kikutani, J. Clin. Immunol., 29, No. 1, 1-11 (2009).

    Article  CAS  PubMed  Google Scholar 

  12. I. Oinuma, Y. Ishikawa, H. Katoh, and M. Negishi, Science, 305, 862-865 (2004).

    Article  CAS  PubMed  Google Scholar 

  13. W. Shi, A. Kumanogoh, C. Watanabe, et al., Immunity, 13, No. 5, 633-642 (2000).

    Article  CAS  PubMed  Google Scholar 

  14. X. Wang, A. Kumanogoh, C. Watanabe, et al., Blood, 97, No. 11, 3498-3504 (2001).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. M. Kuklina.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 157, No. 2, pp. 198-201, February, 2014

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuklina, E.M., Baidina, T.V., Danchenko, I.Y. et al. Semaforin Sema4D in the Immune System in Multiple Sclerosis. Bull Exp Biol Med 157, 234–237 (2014). https://doi.org/10.1007/s10517-014-2533-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-014-2533-x

Keywords

Navigation